#Fight4Hematology Action Hub

ASH submitted a comment letter to the Office of Management and Budget’s (OMB) noting our grave concerns about their proposal to convert the Uniform Guidance for Federal Financial Assistance to a regulation. This would replace a flexible administrative framework with prescriptive requirements, which are less responsive to the evolving needs of medical research and federal grant administration. The new rule would overhaul how grants, cooperative agreements, and other forms of assistance are managed, and it would affect all federal agencies. ASH fears this will weaken the nation’s medical research enterprise and threaten public health. ASH requests that the administration rescind the proposal immediately.

The Office of Management and Budget (OMB), which is part of the executive branch, issued a proposed rule, "Regulation for Federal Financial Assistance," that would apply to all federal departments and agencies and significantly reshape the federal grant-making process. The proposed policy is a sweeping departure from decades of best practices in federal merit-based grantmaking. ASH and others in the medical and scientific community are extremely concerned about the negative impact this proposal will have on the research enterprise, the advancement of science, public health programs, and access to care for vulnerable populations.

The American Society of Hematology (ASH) is funding 33 independent hematology research projects through its Award for Research Careers in Hematology (ARCH) program, the successor award to the ASH Bridge Grant. This cohort is the largest yet, funded in part by ASH’s #Fight4Hematology effort, which was developed in response to ongoing threats to federal research funding.

When faced with dramatic fundings cuts that could weaken scientific research and hematologic advances, ASH jumped into action. Since its launch in 2025, the #Fight4Hematology campaign has become more than a slogan. It's an investment in our members and call to action on behalf of all patients with blood diseases around the world who depend on the treatments made possible by America's medical innovations. Read about the campaign's successes to date, and why ASH is keeping up the #fight.

Seventy-one percent of registered voters believe federal funding for medical research on cures for cancer and other debilitating health issues should increase according to a new national poll.

In an effort to counteract federal research funding cuts, ASH has substantially expanded its Bridge Grant program – awarding one-year, $150,000 grants to 25 investigators to keep groundbreaking hematology research moving forward.

The Trump Administration published details of the President’s Fiscal Year 2027 Budget Request, which includes a proposed cut of $5.787 billion or 12.3% to the National Institutes of Health (NIH). These cuts would harm patients, stall research, and put the U.S. behind other nations in leading the development of groundbreaking cures for blood diseases.